• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricte

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2022 Apr 13;9(7):ofac192.
doi: 10.1093/ofid/ofac192. eCollection 2022 Jul.
Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue Distribution


Ruian Ke[SUP] 1 [/SUP], Pamela P Martinez[SUP] 2 [/SUP], Rebecca L Smith[SUP] 3 [/SUP], Laura L Gibson[SUP] 4 [/SUP], Chad J Achenbach[SUP] 4 [/SUP], Sally McFall[SUP] 5 [/SUP], Chao Qi[SUP] 6 [/SUP], Joshua Jacob[SUP] 7 [/SUP], Etienne Dembele[SUP] 7 [/SUP], Camille Bundy[SUP] 8 [/SUP], Lacy M Simons[SUP] 7 [/SUP], Egon A Ozer[SUP] 7 [/SUP], Judd F Hultquist[SUP] 7 [/SUP], Ramon Lorenzo-Redondo[SUP] 7 [/SUP], Anita K Opdycke[SUP] 9 [/SUP], Claudia Hawkins[SUP] 7 [/SUP], Robert L Murphy[SUP] 7 [/SUP], Agha Mirza[SUP] 10 [/SUP], Madison Conte[SUP] 10 [/SUP], Nicholas Gallagher[SUP] 11 [/SUP], Chun Huai Luo[SUP] 11 [/SUP], Junko Jarrett[SUP] 11 [/SUP], Abigail Conte[SUP] 12 [/SUP], Ruifeng Zhou[SUP] 12 [/SUP], Mireille Farjo[SUP] 2 [/SUP], Gloria Rendon[SUP] 13 [/SUP], Christopher J Fields[SUP] 13 [/SUP], Leyi Wang[SUP] 14 [/SUP], Richard Fredrickson[SUP] 14 [/SUP], Melinda E Baughman[SUP] 3 [/SUP], Karen K Chiu[SUP] 3 [/SUP], Hannah Choi[SUP] 3 [/SUP], Kevin R Scardina[SUP] 3 [/SUP], Alyssa N Owens[SUP] 15 [/SUP], John Broach[SUP] 4 [/SUP], Bruce Barton[SUP] 16 [/SUP], Peter Lazar[SUP] 16 [/SUP], Matthew L Robinson[SUP] 4 [/SUP], Heba H Mostafa[SUP] 11 [/SUP], Yukari C Manabe[SUP] 4 [/SUP], Andrew Pekosz[SUP] 12 [/SUP], David D McManus[SUP] 4 [/SUP], Christopher B Brooke[SUP] 2 [/SUP]



Affiliations
Free PMC article

Abstract

Background: The global effort to vaccinate people against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during an ongoing pandemic has raised questions about how vaccine breakthrough infections compare with infections in immunologically naive individuals and the potential for vaccinated individuals to transmit the virus.
Methods: We examined viral dynamics and infectious virus shedding through daily longitudinal sampling in 23 adults infected with SARS-CoV-2 at varying stages of vaccination, including 6 fully vaccinated individuals.
Results: The durations of both infectious virus shedding and symptoms were significantly reduced in vaccinated individuals compared with unvaccinated individuals. We also observed that breakthrough infections are associated with strong tissue compartmentalization and are only detectable in saliva in some cases.
Conclusions: Vaccination shortens the duration of time of high transmission potential, minimizes symptom duration, and may restrict tissue dissemination.

Keywords: SARS-CoV-2; breakthrough infections; vaccines; viral dynamics.
 
Back
Top Bottom